Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL4107444 | 1.00 | — | — | |
| SCHEMBL505620 | 0.98 | — | — | |
| SCHEMBL16310730 | 0.79 | ALDH1A1 (0.33) | — | |
| SCHEMBL505621 | 0.76 | TXNRD1 (0.36) | — | |
| SCHEMBL18605938 | 0.69 | MAPT (0.44) | — | |
| SCHEMBL5518564 | 0.69 | CA12 (0.44) | — | |
| SCHEMBL13010086 | 0.63 | AGTR1 (0.39) | — | |
| SCHEMBL478999 | 0.62 | MEN1 (0.31) | — | |
| SCHEMBL1408568 | 0.60 | ALDH1A1 (0.44) | — | |
| SCHEMBL16675402 | 0.58 | SMN1; SMN2 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250367165-A1 | EMERGENCY EYE WASH | LEBRUN LABS LLC (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250262123-A1 | EMERGENCY EYE WASH | LEBRUN LABS LLC | 2025-08-21 | — | — | US | disclosed |
| WO-2024249874-A9 | ORIENTATION CONTROLLABLE DIRECT ELECTRON TRANSFER TYPE GLUCOSE DEHYDROGENASES AND THEIR BIOSENSOR APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-04-10 | — | — | WO | disclosed |
| WO-2024249874-A2 | ORIENTATION CONTROLLABLE DIRECT ELECTRON TRANSFER TYPE GLUCOSE DEHYDROGENASES AND THEIR BIOSENSOR APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-12-05 | — | — | WO | disclosed |
| EP-1803460-B1 | Use of a platinum colloid containing aqueous solution for the treatment of psychiatric symptoms | INOVEX CO LTD (JP) | 2012-08-22 | — | — | EP | disclosed |
| US-7820205-B2 | Platinum colloid-containing aqueous solution for treating schizophrenia | INOVEX CO., LTD. (JP) | 2010-10-26 | — | — | US | disclosed |
| US-20080031953-A1 | Composition And Method For Treating Or Preventing Psychiatric Symptom | INOVEX CO., LTD. (JP) | 2008-02-07 | — | — | US | disclosed |
| EP-1803460-A1 | COMPOSITION AND METHOD FOR THERAPY OR PREVENTION OF MENTAL SYMPTOM | Inovex CO., LTD (JP) | 2007-07-04 | — | — | EP | disclosed |